Lipids and diastolic dysfunction: Recent evidence and findings.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
06 2022
Historique:
received: 05 12 2021
revised: 03 02 2022
accepted: 02 03 2022
pubmed: 17 4 2022
medline: 7 6 2022
entrez: 16 4 2022
Statut: ppublish

Résumé

Diastolic dysfunction is the decreased flexibility of the left ventricle due to the impaired ability of the myocardium to relax and plays an important role in the pathogenesis of heart failure. Lipid metabolism is a well-known contributor to cardiac conditions, including ventricular function. In this article, we aimed to review the literature addressing the connections between lipids, their storage, and metabolism with left ventricular diastolic dysfunction. We searched Google scholar, Pubmed, Embase and Researchgate for our keywords: "Diastolic function", "Fat" and "Lipid profile". Initially, 250 articles were selected by title and 84 of them were chosen as most relevant and directly reviewed. Alterations of lipid metabolism in cardiac muscle and cardiac lipid content can occur in many conditions, including consumption of a high-fat diet, obesity, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). These conditions induce alterations in myocardial lipid metabolism, increase myocardial fat content and epicardial fat thickness and increase inflammation and oxidative stress which ultimately lead to cardiac lipotoxicity and diastolic dysfunction. The effects of lipids on diastolic function can differ based on gender. Lipid profile and metabolism are as important in the pathogenesis of diastolic dysfunction as they are in other cardiovascular disorders. A more careful look at cardiac lipid metabolism in molecular, histological and gross levels results in more precise understanding of its role in myocardial function and leads to development of potential treatments for diastolic dysfunction.

Identifiants

pubmed: 35428541
pii: S0939-4753(22)00123-5
doi: 10.1016/j.numecd.2022.03.003
pii:
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1343-1352

Informations de copyright

Copyright © 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interests.

Auteurs

Padideh Daneii (P)

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: padidehdaneii@gmail.com.

Sina Neshat (S)

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: sinaneshat@gmail.com.

Monir Sadat Mirnasiry (MS)

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: Monir.s.mirnasiry@gmail.com.

Zahra Moghimi (Z)

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: z.moghimi1@gmail.com.

Fatemeh Dehghan Niri (F)

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: f.dehghann2014@gmail.com.

Armita Farid (A)

School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: armitafarid@gmail.com.

Masood Shekarchizadeh (M)

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Science, Iran.

Kiyan Heshmat-Ghahdarijani (K)

Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: kiyan_heshmat@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH